Descripción de negocio
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses.
Consejo de gestión & Consejo de supervisión
| CEO |
| Charles Kummeth |
| Consejo de gestión |
| Jim Hippel, Kim Kelderman, Will Geist, Shane Bohnen, Peter Breloer, Qi Cheng, Steve Crouse, Brenda S. Everson, Bob Gavin, Lynne Hohlfeld, Evett Kruka, Steven Silverman, Kevin Smyth, Peter Schuessler |
| Consejo de supervisión |
| Robert V. Baumgartner, Charles Kummeth, Dr. Alpna Seth, Dr. Joseph D. Keegan, Dr. Randolph C. Steer, Dr. Roland Nusse, Dr. Rupert Vessey, John L. Higgins, Julie L. Bushman |
Datos de la empresa
| Nombre: |
Bio-Techne Corp. |
| Dirección: |
614 McKinley Place N.E.,Minneapolis, MN 55413, USA |
| Teléfono: |
+1-612-379-2956 |
| Fax: |
+1-612-656-4400 |
| E-mail: |
info@bio-techne.com
|
| Internet: |
bio-techne.com/ |
| Industria: |
Healthcare |
| Sector: |
Medical Products |
| Subsector: |
Advanced Medical Devices |
| Fin del año financiero: |
30/06 |
| Acciones de libre circulación: |
79.40% |
| Fecha de OPI: |
08/05/1989 |
Relación con inversores
| Nombre: |
David Clair |
| IR teléfono: |
+1-612-656-4416 |
| IR-fax: |
- |
| IR e-mail: |
ir@bio-techne.com
|
